You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for 4EGI-1
4EGI-1 is an inhibitor of eIF4E:eIF4G interaction; prevents eIF4E binding to eIF4G. Binds eIF4E and inhibits cap-dependent translation but not initiation factor-independent translation. Exhibits activity against Jurkat and A549 cells.
Technical Data for 4EGI-1
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for 4EGI-1
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for 4EGI-1
The following data is based on the product molecular weight 451.28. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.22 mL||11.08 mL||22.16 mL|
|5 mM||0.44 mL||2.22 mL||4.43 mL|
|10 mM||0.22 mL||1.11 mL||2.22 mL|
|50 mM||0.04 mL||0.22 mL||0.44 mL|
References for 4EGI-1
References are publications that support the biological activity of the product.
Gkogkas et al (2013) Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493 371 PMID: 23172145
Moerke et al (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128 257 PMID: 17254965
If you know of a relevant reference for 4EGI-1, please let us know.
View Related Products by Target
Keywords: 4EGI-1, 4EGI-1 supplier, eIF4E, eIF4G, inhibitors, inhibits, interaction, cap-dependent, translation, DNA,, RNA, and, Protein, Synthesis, Protein-synthesizing, GTPases, 4800, Tocris Bioscience
1 Citation for 4EGI-1
Citations are publications that use Tocris products. Selected citations for 4EGI-1 include:
Riz et al (2016) Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming. Oncotarget 7 66360 PMID: 27626179
Do you know of a great paper that uses 4EGI-1 from Tocris? Please let us know.
Reviews for 4EGI-1
Average Rating: 4 (Based on 1 Review.)
Have you used 4EGI-1?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Cells were treated with MG-132 (15 µM) for 18 hours in the absence or presence of an eIF4E/eIF4G interaction inhibitor (4EGI-1, 50 µM) or an MNK inhibitor (CGP57380, 10 μM).